This study is testing an investigational asthma treatment targeting inflammation in the airways.
SIGN-UPAdults ages 18–65 with asthma may qualify for a clinical research study. The study is testing an investigational asthma treatment targeting inflammation in the airways. Participants will continue their regular inhalers during the study, complete a series of study visits, and receive study-related health exams, labs, and ECGs.
.png){kind=icon}
Open to participants in the Raleigh, NC area—conveniently located near UNC-REX Hospital.
.png){kind=icon}
Participants must be ages 18–65 and diagnosed with asthma for at least 12 months.
.png){kind=icon}
Complete 16 visits over 12 months
.png){kind=icon}
Study-related physical exams, labs, and ECGs provided, plus compensation up to $2,000 for time and travel.
Additional criteria may apply
Participants will receive study-related physical exams, lab work, and ECGs at no cost. In addition, compensation of up to $2,000 is available to cover time and travel related to study participation.
Read More.png)
.png)
Mattis non quis donec quisque. Turpis donec tempus sed ipsum pellentesque nunc et et. Integer et feugiat diam non nec, adipiscing nisl.
Adults ages 18–65 who have been diagnosed with asthma for more than 12 months may qualify. Additional criteria apply.
No. Participants will continue using their current rescue and/or daily controller inhalers throughout the study.
The study includes 16 visits over 12 months at North Carolina Clinical Research in Raleigh, near UNC-REX Hospital.
Yes. Participants may receive up to $2,000 for time and travel, along with study-related exams, labs, and ECGs at no cost.
